|
| Aprovel® |
 |
(irbesartan)
Aprovel® belongs to the most recent class of anti-hypertension drugs: angiotensin II receptor antagonists.
Aprovel® has obtained an extension of indication in the treatment of renal disease in patients with high blood pressure and type 2 diabetes, in June 2002 for Europe and September 2002 in the United States.
|
| CoAprovel® |
|
(irbesartan and hydrochlorothiazide)
The association of irbesartan with a diuretic, makes it possible to treat patients whose blood pressure is insufficiently controlled by irbesartan or the diuretic alone with similar tolerance.
|
| Tritace® |
|
(ramipril)
An ACE inhibitor used to reduce the risk of cardiovascular problems in high-risk patients, to lower blood pressure and help slow the progression of renal disease.
|
Tritrace 1.25mg, 2.5mg, 5mg
|
Tritrace comp and comp LS
|
| Updated: September 15, 2006 |
|
|
|
